By interacting with the enzyme, tyrosinase can reduce melanin production and stimulate the creation of lighter-colored pheomelanin over darker eumelanin
When Novo Nordisk announced that their clinical trial of semaglutide, the glucagon-like peptide-1 (GLP-1) drug, sold in different formulations as Rybelsus, Wegovy, and Ozempic, failed to treat early-stage Alzheimers across the more than 3,800 trial participants, researchers who spoke to Being Patient were eager to see the full data
Hormonal changes during GLP-1 therapy GLP-1 therapy creates a hormonal environment that is distinctly different from caloric restriction alone
C12571500BT) supplemented with 3 mg/ml BSA, 0.23 mM pyruvic acid, 50 g/ml vitamin C, 0.03 U/ml FSH (follicle-stimulating hormone, Sigma
This provides near double the weight loss to GLP-1 agonists and significant glucose lowering, as well as promising efficacy in non-alcoholic fatty liver disease